ME News and Press, 23andMe Holding Co. From 03/19/24

SOUTH SAN FRANCISCO, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, released an exciting new feature for 23andMe+ Premium and Total Health members, that uncovers DNA connections to 335 unique historical individu...

SOUTH SAN FRANCISCO, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, released three new genetic reports for 23andMe+ members on breast, colorectal and prostate cancer. The reports are based on statistical models ...

SOUTH SAN FRANCISCO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading human genetics and biopharmaceutical company, today announced an oral presentation and two poster presentations on two of the Company’s immuno-oncology prog...

2024-02-17 01:01:00 ET Summary While we may use statistical measures like volatility or correlation to measure risk in practice, risk is not a statistical abstraction. Business owners can try to insulate themselves from catastrophic risk, but those protections may not exist, and e...

2024-02-13 09:53:00 ET Genetic-testing company 23andMe (NASDAQ: ME) is a household name, but does that make it a smart investment? After all, if the tangible health benefits of learning more about your genome are as significant as the company claims, people would be rushing en masse...

2024-02-08 13:15:15 ET More on 23andMe 23andMe Holding Co. (ME) Q3 2024 Earnings Call Transcript 23andMe GAAP EPS of -$0.58, revenue of $44.7M misses by $11.6M 23andMe reportedly mulling split of company to maintain listing Seeking Alpha’s Quant Rating...

2024-02-07 21:22:04 ET 23andMe Holding Co. (ME) Q3 2024 Earnings Conference Call February 07, 2024 04:30 PM ET Company Participants Ian Cooney - Senior Director of Investor Relations Anne Wojcicki - Co-Founder and Chief Executive Officer Joseph Selsavage - Interi...

2024-02-07 16:48:07 ET More on 23andMe 23andMe reportedly mulling split of company to maintain listing 23andMe facing mounting litigation over hacking incident Seeking Alpha’s Quant Rating on 23andMe Historical earnings data for 23andMe Financi...

2024-02-07 16:03:18 ET More on 23andMe 23andMe facing mounting litigation over hacking incident Hackers accessed personal data for 6.9M 23andMe users: report Seeking Alpha’s Quant Rating on 23andMe Historical earnings data for 23andMe Financial...

SOUTH SAN FRANCISCO, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, reported its financial results for the third quarter of fiscal year 2024 (FY24), which ended December 31, 2023. Key Results Report...